Balance wanting low prices for generics but also wanting enough competitors in the market.
The Indian pharmaceutical industry has become almost synonymous with the US regulatory authorities. The Indian firms that have slowly expanded their market share in the generics segment have been facing…
Threat to Indian pharmaceutical company, may cost more than 6 thousand crores in the US
A total of 44 US states on Monday filed a lawsuit against as many as 20 generic drug manufacturers, including seven Indian firms. Among these Indian firms, 5 have been…
Large pharma companies increase prices ofgeneric drugs by up to one thousand percent
Leading drug companies including Teva, Pfizer, Novartis and Mylan conspired to inflate the prices of generic drugs by as much as 1,000 percent, according to a far-reaching lawsuit filed on…
